BioSpace News Archive

Delaying surgery for 12 months or more after a rotator cuff tear diagnosis is associated with almost twice the odds of needing a subsequent revision surgery compared to having surgery between six weeks and one year after diagnosis, according to a retrospective study of records from thousands of patients across the United States by investigators at Hospital for Special Surgery.

Notch Therapeutics Inc., a cell therapy company with a proprietary platform for generating renewable stem cell-derived T cell therapies for cancer and other immune disorders, announced today the appointment of Kamran Alam as Executive Vice President, Finance and Chief Financial Officer and Gregory Block as Senior Vice President, Corpo

The National Kidney Foundation (NKF) national governing Board of Directors has named nephrologist Dr. Sylvia E. Rosas of the Joslin Diabetes Center in Boston as the president-elect, with a term as president to begin in October 2022 .

Sesen Bio (Nasdaq:SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that the Company has selected Cardinal Health as its exclusive provider for third-party logistics (3PL) and specialty pharmaceutical distribution services related to the commercial distribution of Vicineum in the United States (U.S.). The Company’s lead progr

Oral presentation at Clinical Trials on Alzheimer’s Disease 2020 will include baseline characteristics of the Phase 2/3 GAIN Trial ahead of planned interim analysis expected to occur before year-end 2020 -- -- Poster at Society for Immunotherapy of Cancer Annual Meeting evaluates the therapeutic potential of gingipain inhibitors in oncology -- SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )-- Cortexyme, Inc. (Nasdaq: CRTX), a clinical stag

- Five Oral Presentations, Ten Digital Posters Highlight Varian Products and Innovation - Ethos® Data Presented in Five Types of Cancer, Demonstrating Benefits of Adaptive Therapy - First Data from Newly-Formed AI-Driven Adaptive Intelligence Consortium Presented

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today announced the development of a highly neutralizing monoclonal antibody AR-711, discovered from convalescent COVID-19 patients, that success

TransCelerate Biopharma Inc. (TransCelerate) announced today that it has launched a number of new initiatives to improve the research and development of medicines. These new initiatives further TransCelerate’s mission to collaborate across the global biopharmaceutical research and development community to identify, prioritize and facilita

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the third quarter 2020 on Thursday, October 29, 2020, following the close of the market. The company will discuss these results in a conference call scheduled for 3 PM Pacific Time (6 PM Eastern Time) that day. To listen, call 855-779-9068 within the U.S. or 6

Cerus Corporation (Nasdaq:CERS) announced today that its third quarter 2020 financial results will be released on Thursday, October 29, 2020, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook. To listen to the live webcast and